Preparing for global pandemics

22 August 2016

By Dr Nicola Davies

Scientists, researchers, innovators, and entrepreneurs from Europe gathered to discuss new discoveries at the 2016 EuroScience Open Forum (ESOF) in Manchester at the end of July. “The next Plague – preparing for global pandemics” was a topic of particular interest, with debate centering on the direction research should take in combating pandemics.

During his presentation, the chief scientific officer of Johnson & Johnson (NYSE: JNJ), Paul Stoffels, pointed out that collaboration between government, industry, and research institutions was essential. The Center for Disease Control (CDC) Influenza Division International Program already has numerous preparations in place to help public health authorities in the event of a pandemic.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK